Literature DB >> 26689870

Efficacy of ibrutinib in the treatment of Bing-Neel syndrome.

Aurélie Cabannes-Hamy1,2, Richard Lemal3,4, Lauriane Goldwirt5, Stéphanie Poulain6,7, Sandy Amorim1,2, Renan Pérignon8, Juliette Berger9, Pauline Brice1, Eric De Kerviler10, Jacques-Olivier Bay3,4, Helene Sauvageon5, Kheira Beldjord11, Samia Mourah5, Olivier Tournilhac3,4, Catherine Thieblemont1,2,11.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 26689870     DOI： 10.1002/ajh.24279

Source DB:  PubMed          Journal:  Am J Hematol        ISSN： 0361-8609            Impact factor:   10.047


× No keyword cloud information.
  20 in total

1.  Standard Dose of Ibrutinib is Effective in the Treatment of Bing-Neel Syndrome.

Authors:  Mark Plander; Tamás Szendrei; Árpád Vadvári; János Iványi
Journal:  Pathol Oncol Res       Date:  2018-10-25       Impact factor: 3.201

2.  Imaging spectrum of Bing-Neel syndrome: how can a radiologist recognise this rare neurological complication of Waldenström's macroglobulinemia?

Authors:  Aikaterini Fitsiori; Luc-Matthieu Fornecker; Laurence Simon; Alexandros Karentzos; Damien Galanaud; Olivier Outteryck; Patrick Vermersch; Jean-Pierre Pruvo; Emmanuel Gerardin; Christine Lebrun-Frenay; Francois Lafitte; Jean-Philippe Cottier; Christine Clerc; Jerome de Seze; Jean-Louis Dietemann; Stephane Kremer
Journal:  Eur Radiol       Date:  2018-06-19       Impact factor: 5.315

3.  First-line ibrutinib for Bing-Neel syndrome.

Authors:  Aaron Tallant; Daniel Selig; Sam O Wanko; Joseph Roswarski
Journal:  BMJ Case Rep       Date:  2018-10-02

4.  Outcomes in 370 patients with mantle cell lymphoma treated with ibrutinib: a pooled analysis from three open-label studies.

Authors:  Simon Rule; Martin Dreyling; Andre Goy; Georg Hess; Rebecca Auer; Brad Kahl; Nora Cavazos; Black Liu; Shiyi Yang; Fong Clow; Jenna D Goldberg; Darrin Beaupre; Jessica Vermeulen; Mark Wildgust; Michael Wang
Journal:  Br J Haematol       Date:  2017-08-18       Impact factor: 6.998

Review 5.  Current Status of Bruton's Tyrosine Kinase Inhibitor Development and Use in B-Cell Malignancies.

Authors:  Andrew Aw; Jennifer R Brown
Journal:  Drugs Aging       Date:  2017-07       Impact factor: 3.923

6.  Guideline for the diagnosis, treatment and response criteria for Bing-Neel syndrome.

Authors:  Monique C Minnema; Eva Kimby; Shirley D'Sa; Luc-Matthieu Fornecker; Stéphanie Poulain; Tom J Snijders; Efstathios Kastritis; Stéphane Kremer; Aikaterini Fitsiori; Laurence Simon; Frédéric Davi; Michael Lunn; Jorge J Castillo; Christopher J Patterson; Magali Le Garff-Tavernier; Myrto Costopoulos; Véronique Leblond; Marie-José Kersten; Meletios A Dimopoulos; Steven P Treon
Journal:  Haematologica       Date:  2016-10-06       Impact factor: 9.941

7.  Ibrutinib Treatment of Mantle Cell Lymphoma Relapsing at Central Nervous System: A Case Report and Literature Review.

Authors:  Donato Mannina; Barbara Loteta
Journal:  Case Rep Hematol       Date:  2017-07-16

8.  Bing-Neel Syndrome with Detectable MYD88 L265P Gene Mutation as a Late Relapse Following Autologous Hematopoietic Stem Cell Transplantation for Waldenström's Macroglobulinemia.

Authors:  Anna J Kopińska; Grzegorz Helbig; Anna Koclęga; Sławomira Kyrcz-Krzemień
Journal:  Turk J Haematol       Date:  2017-06-05       Impact factor: 1.831

Review 9.  Central nervous system localisation of chronic lymphocytic leukaemia, description of two very distinct cases and a review of the literature.

Authors:  Nyanza K L M Timmers; Josanne S de Maar; Rob C M van Kruijsdijk; Saskia K Klein
Journal:  Ann Hematol       Date:  2018-04-29       Impact factor: 3.673

10.  Successful Treatment of Chronic Lymphocytic Leukemia Multifocal Central Nervous System Involvement with Ibrutinib.

Authors:  Anna Christoforidou; Georgios Kapsas; Zoe Bezirgiannidou; Spyros Papamichos; Ιoannis Kotsianidis
Journal:  Turk J Haematol       Date:  2018-02-02       Impact factor: 1.831
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.